Document Detail


Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial.
MedLine Citation:
PMID:  11529537     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: This study confirmed the gain in H-SDS CA in Noonan's syndrome during long-term GH treatment. However, the accelerating effect of GH on bone maturation seemed to compromise the final height prognosis.
Authors:
C Noordam; I Van der Burgt; R C Sengers; H A Delemarre-van de Waal; B J Otten
Related Documents :
10443647 - Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery ...
15559337 - Ablative or excisional laparoscopic surgery for endometriotic cysts: resolving the issue.
5946547 - Achondroplastic dwarfism. effects of treatment with human growth hormone.
9007857 - Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereo...
17920887 - Introduction of a new mobile-bearing total knee prosthesis: minimum three year follow-u...
18206597 - Importance of the new radiographic sign of fecal loading in the cecum in the presence o...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Acta paediatrica (Oslo, Norway : 1992)     Volume:  90     ISSN:  0803-5253     ISO Abbreviation:  Acta Paediatr.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-08-31     Completed Date:  2002-01-03     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  9205968     Medline TA:  Acta Paediatr     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  889-94     Citation Subset:  IM    
Affiliation:
Department of Paediatric Endocrinology, University Medical Centre St Radboud, Nijmegen, The Netherlands. C.Noordam@ckskg.azn.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Analysis of Variance
Body Height / drug effects*
Child
Child, Preschool
Female
Growth Hormone / therapeutic use*
Humans
Male
Noonan Syndrome / drug therapy*
Prospective Studies
Time Factors
Chemical
Reg. No./Substance:
9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of enteral nutrition on antioxidant enzyme systems and inflammation in paediatric Crohn's dis...
Next Document:  The breech presentation and the vertex presentation following an external version represent risk fac...